Dr. Anil Patil

DFE Pharma opens new Centre of Excellence in Hyderabad

DFE Pharma, the Germany-based pharma – and nutraceutical excipient solutions provider, recently opened its new Centre of Excellence –‘Closer to the Formulator’ (C2F) - in Hyderabad. The inauguration was attended by Mr. K.T. Rama Rao, Minister for IT, Industries & Commerce, Municipal Administration & Urban Departments of the Telangana government along with Mr. Jayesh Ranjan, IAS, Principal Secretary, Industries and Commerce, Government of Telangana, Mr. Shakthi Nagappan, Director (Life Sciences & Pharma), Government of Telangana and DFE Pharma’s leadership team and senior representatives of leading pharmaceutical companies. The centre is based in Genome Valley, the largest pharma and life sciences hub in Asia. Speaking on the occasion, Mr. Rama Rao, said, “I fi rmly believe that C2F will further strengthen the potential for growth and support offered by Genome Valley. The Government of Telangana will work with DFE Pharma to ensure that life sciences companies in the state leverage from this facility.” DFE Pharma said the C2F will help pharmaceutical companies to shorten the time from concept to fi nished commercial product through its expertise in all phases of pharmaceutical development. The services offered by the new centre mainly focus on oral solid dosage (OSD) forms and comprise a range of pre-registration work including development, scale-up, and technology transfer. The capabilities also include effi ciency projects like conversions from wet granulation to direct compression. The centre works with active pharmaceutical ingredients (APIs), including innovative concepts as model APIs; and with a broad portfolio of all categories of excipients and their different grades.

Mr. Martti Hedman, CEO of DFE Pharma commented, “With our C2F centre, based at a prime location in the pharma and life sciences hub Genome Valley, we can help pharmaceutical and nutraceutical companies progress their projects faster and further. Through our capabilities, we not only support our customers to develop high-quality products but also improve their effi - ciencies.” “We aim to closely work with our customers to help them develop new ideas, together we address their challenges using our expertise in the latest pharmaceutical trends” explained Dr. Anilkumar Gandhi, Director of the C2F Centre of Excellence. “The capabilities offered through this centre can reduce the time to launch a product, without compromising quality, while reducing the number of development assays and therefore decreasing formulation spending,” he added.

PM calls for concerted efforts to make India global centre of research and innovation

Prime Minister Narendra Modi has called for concerted efforts to make India a global centre of research and innovation, and urged state governments to frame modern policies in the fi elds of science and technology. Mr. Modi lamented that unlike the western countries, India failed to adequately celebrate the works of its scientists, which turned a large section of the society indifferent towards science.

There is a need to celebrate the achievements of Indian scientists, he emphasised, while virtually addressing the inaugural session of the Centre-State Science Conclave organised recently in Ahmedabad.

Assam captivate 16 ethanol projects worth Rs. 3,290-crore

Assam attracts 16 ethanol projects worth Rs. 3,290-crore

Assam has attracted 16 ethanol projects worth Rs. 3,290-crore under its Ethanol Production Promotion Policy, 2021, the State’s Chief Minister Himanta Biswa Sarma informed. He recently held a meeting with the promoters of seven ethanol manufacturing entities who had come forward under the policy to set up their plants. During the meet the promoters apprised the Chief Minister of their latest developments and issues. The seven entities are presently ready to commence construction and commercial production of bio-fuel by the middle of 2023. Six out of seven entities have been provided with land in Industrial Development Corporation Industrial Parks across various parts of the State including two units in IGC Matia, one unit each at Industrial Landbank in Sipajhar, ID Dhing, IGC Balipara and near Assam Plastic Park, Tinsukia. The proposed annual capacity of these seven units is 970-kld with planned investment of Rs. 1,154-crore.

trinamiX Face Authentication by BASF

trinamiX Face Authentication is the first to be certified as highly secure behind OLED

The first face authentication to pass Android Biometric Security Test and FIDO Biometric Component Certification, while the hardware is mounted behind an OLED display
Solution officially approved for integration into Android phones as well as for use in particularly sensitive applications

trinamiX Face Authentication is the world’s first to fulfill highest biometric security demands while the hardware is invisibly mounted behind an OLED display. The solution was lately put to the thorough test of accredited assessment institutes. It was certified to be spoof-proof behind OLED according to the top standards defined by AndroidTM and FIDO® Alliance. trinamiX GmbH, a German subsidiary of BASF SE, is thus taking a further step towards creating the next generation of biometric authentication for smartphones.